For Investors

We screen hundreds.

You see one.

Flusso is an international capital advisory firm running institutional fundraising mandates. Every deal is vetted and prepared before it goes anywhere, and most of what approaches us goes nowhere.

What reaches you is the fraction worth your time, aligned to what you actually deploy into.

The Inbound Problem

Deal flow was never the problem. Signal is.

Screening is the most expensive thing a fund does that never shows up as a line item. Analyst hours on decks that die at the first data-room question. Partner meetings that exist to establish basics a one-pager should have carried. Numbers that fall apart on first contact, after three people have already touched them.

And screening cuts both ways. The deals worth the time arrive looking identical to the ones that aren't, same templates, same confident numbers, so attention gets allocated blind. The good deal sits unread while the dead one eats a week. That miss never appears in any report. It appears in someone else's portfolio.

Every fund pays for screening. Most just pay in misses.

Track Record

We've sat where you sit.

Both sides of the table, three continents, one bar for what moves.

Krisztina Németh

$200M+ in transactions across the US, Europe, and MENA.

Alan Mason

Four decades on Wall Street, from Salomon Brothers. $1B+ personally raised.

Andreas Mueller

Active VC at K2X Capital. 25 years in US tech, early at Yelp, LinkedIn, and Skype.

The Bar

Most companies never make it to you.

Before anything moves toward an investor, it clears the same review:

01
Nothing moves on trust

Market size, pipeline, and named logos are checked against something other than the founder's memory.

02
The cap table is clean

Ownership, prior terms, and any structure an IC would flag, checked before distribution.

03
The story survives

We pressure-test the case against the objections your IC will raise, before your team has to.

04
The round has a plan

Raise size, use of funds, and timeline that add up. A raise with a plan behind it, not a random number.

05
The founder holds up

Responsive, prepared, and realistic on terms. If they can't run our diligence, they won't survive yours.

06
The standard never slips

Questions answered same day, data-room gaps closed before you find them, a process that doesn't stall.

After The Send

Four things that are true of every send.

The reason it's on your desk.

Nothing goes out broadside. Every send is matched to your mandate. If we can't say why it fits your fund, it doesn't reach your fund. That rule holds on every deal, without exception.

We know the company, not just the deck.

By the time a deal reaches you, we've been inside it for weeks. The numbers, the team, the questions a committee will ask. Your diligence questions have answers on day one, not in week three.

A pass costs you nothing.

Decline in one line, with or without a reason. No follow-up sequence, no "just circling back," no relationship tax. Though if you tell us why, the next sends gets sharper.

Your feedback compounds.

What you pass on, what you ask about, what almost worked. It all feeds the mandate profile, so each send fits tighter than the last. The next deal you see from us will be better.

The Relationship

You hear from us for a reason.

Tell us your mandate once. From then on, you hear from us when something clears the bar and fits, with the reasoning attached. When nothing fits, you hear nothing. Silence means we're screening, not that we forgot you.

There's no fee, no commitment, and no deal you're obligated to look at. You're not subscribing to anything. You're telling us what would have to be true for a deal to be worth your time, and we only show up when it is.

Everything that reaches you earned it.

Where We Operate

Sector agnostic. Standard specific.

Sector
Agnostic
Recent mandates: healthcare, biotech, B2B SaaS, aerospace, industrials. The standard is the constant, not the vertical.
Stage
Series A +
Series A and beyond, where institutional capital deploys. Seed, when the traction is already significant.
Raise Size
$3M +
Institutional rounds with a defined timeline. Clear use of funds, and a raise the roadmap actually justifies.
Reach
Global
Mandates across the US, Europe, and MENA, with a growing presence in Asia and emerging markets.
2B+
Collectively transacted
90+
Years combined experience
10k+
Investor relationships
900+
Ventures supported
Deal Flow

Tell us what you're deploying into.

Register your mandate →